Remimazolam for Cataract Surgery
Cataract Surgery, Cognitive Impairment
About this trial
This is an interventional treatment trial for Cataract Surgery focused on measuring Midazolam, Remimazolam, Outcomes
Eligibility Criteria
Inclusion Criteria: Adult patients age > 65 years undergoing first eye cataract surgery under local topical anesthesia at the University of California, Los Angeles (UCLA). Both male and female patients American Society of Anesthesiologists Class 2, 3, and 4. Exclusion Criteria: Patients who are unable to consent for the study Patients who are unable to cooperate with the cognitive assessment such as patients with significant visual, auditory, language or other impairment. Patients who are unable to understand simple English commands. Patients who do not wish to have benzodiazepine medication during surgery Patients with a history of severe hypersensitivity reaction to dextran 40 or products containing dextran 40. Patients with chronic pain on opiates. Patients with a history of drug, alcohol abuse/dependence. Patients with BMI > 40. Patients with obstructive sleep apnea (moderate to severe).
Sites / Locations
- Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention
Control
Patients assigned to the study group will receive Remimazolam.
Patients assigned to the control group will receive Midazolam.